Community Schedule

Enter at least 4 characters

1 results showing for: 'atomoxetine'

  • Cap 10 mg
    • Brand Fully subsidised brand. Generic Partners
    • Pharmacode2566826
    • Subsidy $18.41
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine S29 Unapproved medicine supplied under Section 29.
    • Pharmacode2632497
    • Subsidy $18.41
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine
    • Pharmacode2638517
    • Subsidy $43.02
    • Measure / Qty per 28
    (Generic Partners Cap 10 mg to be delisted 01 August 2024)
    (APO-Atomoxetine S29 Cap 10 mg to be delisted 01 August 2024)
  • Cap 18 mg
    • Brand Fully subsidised brand. Generic Partners
    • Pharmacode2566834
    • Subsidy $27.06
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine
    • Pharmacode2637065
    • Subsidy $45.57
    • Measure / Qty per 28
    (Generic Partners Cap 18 mg to be delisted 01 August 2024)
  • Cap 25 mg
    • Brand Fully subsidised brand. Generic Partners
    • Pharmacode2566842
    • Subsidy $29.22
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine
    • Pharmacode2637073
    • Subsidy $44.30
    • Measure / Qty per 28
    (Generic Partners Cap 25 mg to be delisted 01 August 2024)
  • Cap 40 mg
    • Brand Fully subsidised brand. Generic Partners
    • Pharmacode2566850
    • Subsidy $29.22
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine
    • Pharmacode2637081
    • Subsidy $46.21
    • Measure / Qty per 28
    (Generic Partners Cap 40 mg to be delisted 01 August 2024)
  • Cap 60 mg
    • Brand Fully subsidised brand. Generic Partners
    • Pharmacode2566869
    • Subsidy $46.51
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine S29 Unapproved medicine supplied under Section 29.
    • Pharmacode2636050
    • Subsidy $46.51
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine
    • Pharmacode2638525
    • Subsidy $51.31
    • Measure / Qty per 28
    (Generic Partners Cap 60 mg to be delisted 01 August 2024)
    (APO-Atomoxetine S29 Cap 60 mg to be delisted 01 August 2024)
  • Cap 80 mg
    • Brand Fully subsidised brand. Generic Partners
    • Pharmacode2566877
    • Subsidy $56.45
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine S29 Unapproved medicine supplied under Section 29.
    • Pharmacode2632500
    • Subsidy $56.45
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine
    • Pharmacode2638533
    • Subsidy $65.20
    • Measure / Qty per 28
    (Generic Partners Cap 80 mg to be delisted 01 August 2024)
    (APO-Atomoxetine S29 Cap 80 mg to be delisted 01 August 2024)
  • Cap 100 mg
    • Brand Fully subsidised brand. Generic Partners
    • Pharmacode2566885
    • Subsidy $58.48
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine S29 Unapproved medicine supplied under Section 29.
    • Pharmacode2632519
    • Subsidy $58.48
    • Measure / Qty per 28
    • Brand Fully subsidised brand. APO-Atomoxetine
    • Pharmacode2638541
    • Subsidy $65.71
    • Measure / Qty per 28
    (Generic Partners Cap 100 mg to be delisted 01 August 2024)
    (APO-Atomoxetine S29 Cap 100 mg to be delisted 01 August 2024)
  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply